Chart, page-2984

So I'll say #3 of my list is something that might be creating a bit of a lag in growth.

"Dragon 2 Study commenced, a trial looking at several parameters, including protocols to significantly decrease theacquisition time for FerriScan and FerriSmart. To date, Resonance Health has obtained data sets from over 85 trial subjects,containing images collected via several acquisition protocols of varying scan times. Work is underway to test the new protocolacross multiple scanner manufacturers;"

Time is money on these incredibly expensive and in demand machines. If they are able to reduce this scan time, they will have greater acceptance by the market. This might very well be the reason it hasn't exploded in popularity across the world.
I would like to know how time intensive these aforementioned scans take in comparison to a standard investigative scan or a biopsy.

Hopefully they can get it worked out without further FDA approvals for modifications to the platform.

While 480+ centres is a decent starting number, I can't help but wonder why it's not 4,800+ centres world wide and maybe expediting the test is the key.

DYOR and IMO